If the JSE was a painful place in 2018, then punters who doggedly pursued opportunities in the small-and mid-cap sector will probably show the deepest scars. Officially the small-cap index fell about 18% in 2018, with the mid-cap index crimping 11%. The JSE industrial board, home to a slew of small-and mid-cap stocks, was off a hefty 20%, while the AltX (which includes many entrepreneurial counters) was off 12%. A good number of former small-and mid-cap darlings came a horrible cropper during the year. These include Ascendis Health (down about 78%), Blue Label Telecoms (down over 60%), private education group Curro (down 40%), Metrofile (35% lower), Zeder Investments (down 35%) and industrial giant Invicta (down 32%). The market was not in a forgiving mood when it came to perusing negative news or strategic setbacks. Predictably, there was persistent chatter as some large fund managers abandoned small-cap mandates and set market capitalisation floors for their portfolios. Which does...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.